Assessment of the accuracy of multi-parametric MRI with PI-RADS 2.0 scoring system in the discrimination of suspicious prostatic focal lesions

Egyptian Journal of Radiology and Nuclear Medicine

Volumn 47, Issue 3, 2016, Pages 1075-1082

  El Samei, Hoda A El Kareem A ^a   Amin, Mohamed Farghaly ^b   Hassan, Ebtesam Esmail ^b  

^a AL AZHAR UNIVERSITY   (Egypt)

^b Minia University   (Egypt)

Author keywords

Mp MRI prostate; PI RAD2.0 score; Prostate focal lesions

Indexed keywords

GADOLINIUM PENTETATE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE ADENOMA; PROSTATE BIOPSY; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATE IMAGING REPORTING AND DATA SYSTEM 2 SCORING SYSTEM; PROSTATITIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 84969610587     PISSN: 0378603X     EISSN: 20904762     Source Type: Journal    
DOI: 10.1016/j.ejrnm.2016.04.022     Document Type: Article

References (29)

1. (1) Cornfeld, D.M., Weinreb, J.C., MR imaging of the prostate: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15 (2007), 433–448.
2. (2) Dickinson, L., Ahmed, H.U., Allen, C., et al. Magnetic resonance imaging for the detection, localization, and characterization of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59 (2011), 477–494.
3. (3) Daniel, J., Georg, S., Michael, E., et al. Evaluation of the PI-RADS Scoring System for classifying mpMRI findings in men with suspicion of prostate cancer. BioMed Res Int, 2013, 9, 252939.
4. (4) Barentsz, J.O., Richenberg, J., Clements, R., et al. ESUR prostate MR guidelines 2012. Eur Radiol 22 (2012), 746–757.
5. (5) Joyce, G.R., Jelle, O.B., Standardization of multiparametric prostate MR imaging using PI-RADS (Review Article). BioMed Res Int Vol, 2014, 9, 431680.
6. (6) Hamoen, E.H., de Rooij, M., Witjes, J.A., et al. Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Euro Urol 67 (2015), 1112–1121.
7. (7) Jelle, O.B., Jeffrey, C.W., Sadhna, V., et al. Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Euro Urol 69 (2016), 41–49.
8. (8) Muller, B.G., Shih, J.H., Sankineni, S., et al. Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging. Radiology 277:3 (2015), 741–750.
9. (9) Röthke, M., Blondin, D., Schlemmer, H.P., et al. PI-RADS classification: structured reporting for MRI of the prostate. Clin Men's Health, 2013 MAGNETOM Flash | 4 / www.siemens.com/magnetom-world.
10. (10) Meltem, E., Mehmet, R., Nusret, A., et al. Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis. Quant Imag Med Surg 3:4 (2013), 210–216.
11. (11) Rosenkrantz, A.B., Kim, S., Lim, R.P., et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269:2 (2013), 482–492.
12. (12) Schlemmer, H.P., Multiparametric MRI of the prostate: method for early detection of prostate cancer. Fortschr Rontgenstr 182 (2010), 1067–1075.
13. (13) Franiel, T., Multiparametric magnetic resonance imaging of the prostate – technique and clinical applications. Fortschr Rontgenstr, 2011, 607–617.
14. (14) Leonardo, K.B., Geert, L., Christina, A.H., et al. Prostate cancer: the european society of urogenital radiology prostate imaging reporting and data system criteria for predicting extra-prostatic extension by using 3-T multiparametric MR imaging. Radiology 2 (2015), 479–489 August.
15. (15) Baur, A.D., Maxeiner, A., Franiel, T., et al. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate. Invest Radiol 49:6 (2014), 411–420.
16. (16) Zelhof, B., Pickles, M., Liney, G., et al. Correlation of diffusion weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 103:7 (2009), 883–888.
17. (17) Koo, J.H., Kim, C.K., Choi, D., et al. Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T. Korean J Radiol 14 (2013), 61–69.
18. (18) Noha, M.A., Hytham, H.E., Essam, A.A., The role of diffusion–Weighted MRI in evaluation of prostate cancer. Egypt J Radiol Nucl Med, 2013 Available online 23 December 2013.
19. (19) Sato, C., Naganawa, S., Nakamura, T., et al. Differentiation of non-cancerous tissue andcancer lesions by apparent diffusion coefficient values intransition and peripheral zones of the prostate. J Magn Reson Imag 21 (2005), 258–262.
20. (20) Akin, O., Sala, E., Moskowitz, C.S., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239 (2006), 784–792.
21. (21) Sandeep, S., Murat, O., Peter, L.C., Functional MRI in prostate cancer detection. BioMed Res Int Vol, 2014, 8, 590638.
22. (22) Alonzi, R., Padhani, A.R., Allen, C., Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63 (2007), 335–350.
23. (23) Sciarra, A., Panebianco, V., Ciccariello, M., et al. Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer. Cancer Invest 28 (2010), 424–432 (51, 52).
24. (24) Hara, N., Okuizumi, M., Koike, H., et al. Dynamic contrast-enhanced magnetic resonance imaging (DCEMRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005), 140–147.
25. (25) Schimmöller, L., Quentin, M., Arsov, C., et al. Inter-readeragreement of the ESUR score for prostate MRI using inboreMRI-guided biopsies as the reference standard. Euro Radiol 23:11 (2013), 3185–3190.
26. (26) Portalez, D., Mozer, P., oisCornud, F., et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Euro Urol 62:6 (2012), 986–996.
27. (27) Sciarra, A., Barentsz, J., Bjartell, A., et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 59:6 (2011), 962–977.
28. (28) Daniel, J.A., Margolis, Multiparametric MRI for localized prostate cancer: lesion detection and staging (Review Article). BioMed Res Int, 2014, 11, 684127.
29. (29) Alistair, D.R., Manik, S.C., Rick, P., et al. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scores in a transperineal prostate biopsy setting. BJU Int 115:5 (2015), 728–735.